DAFNA Capital Management LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1389933
LOS ANGELES, CA
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,002,480
-$93,480 QoQ
Shares Held
400,248
-7.0% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#70
of 316 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DAFNA Capital Management LLC holds $22,367,669 across 6 Drug Manufacturers - Specialty & Generic names. BCRX ranks #3 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
57,769 | $9,736,387 | |
| 2 | ALKS |
Alkermes plc.
|
101,266 | $5,306,338 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
400,248 | $4,002,480 | |
| 4 | AQST |
Aquestive Therapeutics, Inc.
|
645,915 | $2,687,006 | |
| 5 | SCYX |
Scynexis Inc
|
135,868 | $552,982 | |
| 6 | ADCT |
ADC Therapeutics SA
|
77,081 | $82,476 |
All Filings in BCRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,002,480 | 400,248 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,095,960 | 430,248 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,262,389 | 418,255 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,656,555 | 218,255 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,955,564 | 218,255 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,186,912 | 558,255 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,015,840 | 667,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,069,200 | 667,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,353,810 | 704,500 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,604,260 | 709,500 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,249,905 | 709,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,616,160 | 652,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,005,760 | 569,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,599,510 | 551,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,881,480 | 251,000 | Shares | Sole | 2023-02-14 | |
| 2020-09-30 | $2,576,735 | 749,051 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,541,682 | 744,051 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $958,102 | 479,051 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||